This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Michigan. Active years: 2015-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2019
Title: Liming Shu: Innovator in Therapeutic Methods
Introduction
Liming Shu is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of therapeutic methods, particularly in the treatment of diseases such as Gaucher disease and Fabry disease. With a total of 2 patents, his work focuses on innovative solutions that address critical health issues.
Latest Patents
Liming Shu's latest patents include glucosylceramide synthase inhibitors and therapeutic methods using the same. These patents disclose glucosylceramide synthase inhibitors and compositions containing them. The methods outlined in these patents detail the use of glucosylceramide synthase inhibitors in treating diseases and conditions where inhibition of glucosylceramide synthase provides a benefit, such as Gaucher disease and Fabry disease.
Career Highlights
Liming Shu is affiliated with the University of Michigan, where he continues to advance research in his field. His work has garnered attention for its potential impact on therapeutic practices and patient care.
Collaborations
Some of Liming Shu's notable coworkers include Scott D Larsen and Akira Abe. Their collaborative efforts contribute to the innovative research being conducted at the University of Michigan.
Conclusion
Liming Shu's contributions to the field of therapeutic methods highlight his dedication to improving health outcomes through innovation. His patents reflect a commitment to addressing significant medical challenges, making him a valuable figure in the realm of invention.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile